Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 13, Issue 1, 2008, Pages

  Infante Cossío, Pedro ^a,b   Cabezas Macián, Antonio ^c   Pérez Ceballos, José Luis ^b   Palomino Nicas, Julián ^b   Gutiérrez Pérez, José Luis ^a,b  

^a Facultad de Odontología

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Bisphosphonates; Cancer; Jaws; Multiple myeloma; Oral complications; Osteonecrosis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CEFADROXIL; CHLORHEXIDINE; IBUPROFEN; PREGABALIN; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE NECROSIS; CANCER THERAPY; CASE REPORT; CONSERVATIVE TREATMENT; DEBRIDEMENT; DENTAL SURGERY; DISEASE ASSOCIATION; FEMALE; HUMAN; JAW; MALE; MOUTHWASH; MULTIPLE MYELOMA; TOOTH EXTRACTION; TOOTH SOCKET; TREATMENT OUTCOME;

AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; MALE; MANDIBULAR DISEASES; MIDDLE AGED; MULTIPLE MYELOMA; OSTEONECROSIS; TOOTH EXTRACTION; WOUND HEALING;

EID: 38549104065     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003 Sep;61(9):1115-7.
2. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004 May;62(5):527-34.
3. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005 Nov;63(11):1567-75.
4. Bagan JV, Jimenez Y, Murillo J, Hernandez S, Poveda R, Sanchis JM, et al. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol. 2006 Mar;42(3):327-9.
5. Dimitrakopoulos I, Magopoulos C, Karakasis D. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases. Int J Oral Maxillofac Surg. 2006 Jul;35(7):588-93.
6. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007 Mar;65(3):369-76.
7. Migliorati CA. Bisphosphonate-associated oral osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Feb;99(2):135.
8. Ponte Fernández N, Estefania Fresco R, Aguirre Urizar JM. Bisphosphonates and oral pathology I. General and preventive aspects. Med Oral Patol Oral Cir Bucal. 2006 Aug 1;11(5):E396-400.
9. Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005 Jul 7;353(1):99-102.
10. Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol. 2005 Dec 1;23(34):8580-7.
11. Calvo-Villas JM, Tapia Torres M, Govantes Rodríguez J, Carreter de Granda E, Sicilia Guillén F. Osteonecrosis of the jaw in patients with multiple myeloma during and after treatment with zoledronic acid. Med Clin (Barc). 2006 Oct 21;127(15):576-9.
12. Clarke BM, Boyette J, Vural E, Suen JY, Anaissie EJ, Stack BC Jr. Bisphosphonates and jaw osteonecrosis: the UAMS experience. Otolaryngol Head Neck Surg. 2007 Mar;136(3):396-400.
13. Jiménez Y, Bagán JV. Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update. Med Oral Patol Oral Cir Bucal 2005;10:Suppl2:E88-91.
14. Schwartz HC. Bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg. 2005 Oct;63(10):1555-6.
15. Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol. 2006 Feb 20;24(6):945-52.
16. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Oct;102(4):433-41.
17. Leite AF, Figueiredo PT, Melo NS, Acevedo AC, Cavalcanti MG, Paula LM, et al. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jul;102(1):14-21.
18. Mortensen M, Lawson W, Montazem A. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review. Laryngoscope. 2007 Jan;117(1):30-4.
19. Pastor-Zuazaga D, Garatea-Crelgo J, Martino-Gorbea R, Etayo-Pérez A, Sebastián-López C. Osteonecrosis of the jaws and bisphosphonates. Report of three cases. Med Oral Patol Oral Cir Bucal. 2006 Jan 1;11(1):E76-9.